Good evening :)
Switch to
Place Order

Suven Pharmaceuticals Ltd

SUVENPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹13,691 cr, stock is ranked 272
Moderate RiskStock is 2.39x as volatile as Nifty
537.8515.55 (+2.98%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹13,691 cr, stock is ranked 272
Moderate RiskStock is 2.39x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
37.79
PB RatioPB Ratio
11.60
Dividend YieldDiv. Yield
0.37%
Sector PESector PE
40.27
Sector PBSector PB
5.39
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Investor PresentationView older 

Aug 16, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020210.380.901.080.110.320.36
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnAug 31, 2021

Suven Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 31, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Suven Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 31, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Copy of Newspaper Publication 
Announced OnAug 16, 2021

Suven Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication | Download

Suven Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication | Download

Cash Dividend 
Ex. DateAug 13, 2021

Final • Div/Share: ₹ 1

See all events